Aptamer blocking S-TLR4 interaction selectively inhibits SARS-CoV-2 induced inflammation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Signal transduction and targeted therapy 2022-04, Vol.7 (1), p.120-120, Article 120
Hauptverfasser:	Yang, Gang, Zhang, Shengnan, Wang, Yuchun, Li, Ling, Li, Yu, Yuan, Deyu, Luo, Fatao, Zhao, Jincun, Song, Xu, Zhao, Yongyun
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/255 631/92/555 Aptamers Aptamers, Nucleotide - genetics Aptamers, Nucleotide - pharmacology Cancer Research Cell Biology COVID-19 Humans Inflammation - drug therapy Inflammation - genetics Internal Medicine Letter Medicine Medicine & Public Health Oncology Pathology SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 TLR4 protein Toll-Like Receptor 4 - genetics Toll-like receptors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!